Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

Circulating anti-p53 antibodies have been described and used as tumoural markers in patients with various cancers and strongly correlate with the p53 mutated status of the tumours. No study has yet looked at the prevalence of such antibodies in skin carcinoma patients although these tumours have bee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moch, C, Moysan, A, Lubin, R, Salmonière, P de La, Soufir, N, Galisson, F, Vilmer, C, Venutolo, E, Pelletier, F Le, Janin, A, Basset-Séguin, N
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364020/
https://ncbi.nlm.nih.gov/pubmed/11747330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados